{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T02:00:44Z","timestamp":1780538444361,"version":"3.54.1"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,4]]},"DOI":"10.1093\/ije\/29.2.362","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T22:23:22Z","timestamp":1027722202000},"page":"362-368","source":"Crossref","is-referenced-by-count":102,"title":["Ten years of serological surveillance in England and Wales: methods, results, implications and action"],"prefix":"10.1093","volume":"29","author":[{"given":"Kate","family":"Osborne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Gay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Hesketh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Morgan-Capner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2000,4]]},"reference":[{"key":"key\n\t\t\t\t20170712061014_R1","unstructured":"Paul JR. Knowledge and Trends in Poliomyelitis: A Summary. Poliomyelitis: papers and discussions presented at the Second International Poliomyelitis Conference. JB Lippencott; Philadelphia, 1951."},{"key":"key\n\t\t\t\t20170712061014_R2","unstructured":"Gear JHS. Distribution of Antibodies to Poliomyelitis Virus in the General Population. Poliomyelitis: papers and discussions presented at the Third International Poliomyelitis Conference. JB Lippencott; Philadelphia, 1954."},{"key":"key\n\t\t\t\t20170712061014_R3","doi-asserted-by":"crossref","unstructured":"Cockburn WC. World aspects of the epidemiology of rubella. Am J Dis Child1969;118:112\u201322.","DOI":"10.1001\/archpedi.1969.02100040114019"},{"key":"key\n\t\t\t\t20170712061014_R4","doi-asserted-by":"crossref","unstructured":"Szmuness W, Dienstag JL, Purcell RH et al. The prevalence of antibody to hepatitis A antigen in various parts of the world: a pilot study. Am J Epidemiol1977;106:392\u201398.","DOI":"10.1093\/oxfordjournals.aje.a112481"},{"key":"key\n\t\t\t\t20170712061014_R5","doi-asserted-by":"crossref","unstructured":"Dienstag JL, Szmuness W, Stevens CE, Purcell RH. Hepatitis A virus infection: new insights from seroepidemiologic studies. J Infect Dis1978;137:328\u201340.","DOI":"10.1093\/infdis\/137.3.328"},{"key":"key\n\t\t\t\t20170712061014_R6","doi-asserted-by":"crossref","unstructured":"Frosner GG, Papaevangelou GJ, Butler R et al. Antibody against hepatitis A in seven European countries. I. Comparison of prevalence data in different age groups. Am J Epidemiol1979;110:63\u201369.","DOI":"10.1093\/oxfordjournals.aje.a112788"},{"key":"key\n\t\t\t\t20170712061014_R7","doi-asserted-by":"crossref","unstructured":"Anderson RM, May RM. Age-related changes in the rate of disease transmission: implications for the design of vaccination programmes. J Hyg Camb1985;94:365\u2013435.","DOI":"10.1017\/S002217240006160X"},{"key":"key\n\t\t\t\t20170712061014_R8","doi-asserted-by":"crossref","unstructured":"Anderson RM, Grenfell BT. Quantitative investigations of different rubella vaccination policies for the control of congenital rubella syndrome (CRS) in the United Kingdom. J Hyg Camb1986;96:305\u201333.","DOI":"10.1017\/S0022172400066079"},{"key":"key\n\t\t\t\t20170712061014_R9","doi-asserted-by":"crossref","unstructured":"Ukkonen P. Rubella immunity and morbidity: impact of different vaccination programs in Finland 1979\u20131992. Scand J Infect Dis1996; 28:31\u201335.","DOI":"10.3109\/00365549609027146"},{"key":"key\n\t\t\t\t20170712061014_R10","doi-asserted-by":"crossref","unstructured":"Chen HJ, Chang MH, Ni YH et al. Seroepidemiology of hepatitis B infection in children: ten years of mass vaccination in Taiwan. JAMA1996;276:906\u201308.","DOI":"10.1001\/jama.276.11.906"},{"key":"key\n\t\t\t\t20170712061014_R11","doi-asserted-by":"crossref","unstructured":"Morgan-Capner P, Wright J, Miller CL, Miller E. Surveillance of antibody to measles, mumps and rubella by age. Br Med J1988; 297:770\u201372.","DOI":"10.1136\/bmj.297.6651.770"},{"key":"key\n\t\t\t\t20170712061014_R12","doi-asserted-by":"crossref","unstructured":"Hesketh LM, Charlett A, Farrington CP, Miller E, Forsey T, Morgan-Capner P. An evaluation of nine commercial EIA kits for the detection of measles specific IgG. J Virol Meth1997;66:51\u201359.","DOI":"10.1016\/S0166-0934(97)02210-6"},{"key":"key\n\t\t\t\t20170712061014_R13","unstructured":"Ramsay ME, Gay NJ, Miller E et al. The epidemiology of measles in England and Wales: rationale for the 1994 national vaccination campaign. Commun Dis Rep1994;4:R141\u201346."},{"key":"key\n\t\t\t\t20170712061014_R14","doi-asserted-by":"crossref","unstructured":"Gay NJ, Hesketh LM, Morgan-Capner P, Miller E. Interpretation of serological surveillance data for measles using mathematical models: implications for vaccine strategy. Epidemiol Infect1995;115: 139\u201356.","DOI":"10.1017\/S0950268800058209"},{"key":"key\n\t\t\t\t20170712061014_R15","unstructured":"Gay NJ, Ramsay ME, Cohen BJ et al. The epidemiology of measles in England and Wales since the 1994 vaccination campaign. Commun Dis Rep1997;7:R17\u201321."},{"key":"key\n\t\t\t\t20170712061014_R16","unstructured":"Hesketh LM, Rowlatt JD, Gay NJ, Morgan-Capner P, Miller E. Childhood infection with hepatitis A and B viruses in England and Wales. Commun Dis Rep1997;7:R60\u201363."},{"key":"key\n\t\t\t\t20170712061014_R17","doi-asserted-by":"crossref","unstructured":"Gay NJ, Hesketh LM, Osborne KP, Farrington CP, Morgan-Capner P, Miller E. The prevalence of hepatitis B infection in adults in England and Wales. Epidemiol Infect1999;122:133\u201338.","DOI":"10.1017\/S0950268898001745"},{"key":"key\n\t\t\t\t20170712061014_R18","doi-asserted-by":"crossref","unstructured":"Farrington CP. Modelling forces of infection for measles, mumps and rubella. Stat Med1990;9:953\u201367.","DOI":"10.1002\/sim.4780090811"},{"key":"key\n\t\t\t\t20170712061014_R19","unstructured":"Gay NJ, Hesketh LM, Cohen BJ et al. Age specific antibody prevalence to parvovirus B19: how many women are infected in pregnancy? Commun Dis Rep1994;4:R104\u201307."},{"key":"key\n\t\t\t\t20170712061014_R20","doi-asserted-by":"crossref","unstructured":"Osborne KP, Weinberg J, Miller E. The European Sero-Epidemiology Network. Eurosurveillance1997;2:29\u201331.","DOI":"10.2807\/esm.02.04.00167-en"},{"key":"key\n\t\t\t\t20170712061014_R21","unstructured":"Gay NJ, Miller E, Hesketh LM et al. Mumps surveillance in England and Wales supports the introduction of two dose vaccination schedule. Commun Dis Rep1997;7:R21\u201326."},{"key":"key\n\t\t\t\t20170712061014_R22","unstructured":"Miller E, Waight PA, Gay NJ et al. The epidemiology of rubella in England and Wales before and after the 1994 measles-rubella vaccination campaign: fourth joint report from the PHLS and the National Congenital Rubella Surveillance Programme. Commun Dis Rep1997;7:R26\u201332."},{"key":"key\n\t\t\t\t20170712061014_R23","unstructured":"Esveld M. Serological surveillance in the Netherlands. Commun Dis Rep1994;4:107\u201308."},{"key":"key\n\t\t\t\t20170712061014_R24","doi-asserted-by":"crossref","unstructured":"Fleming DT, McQuillan GM, Johnson RE et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med1997;337: 1105\u201311.","DOI":"10.1056\/NEJM199710163371601"},{"key":"key\n\t\t\t\t20170712061014_R25","unstructured":"Anderson RM, May RM. Infectious Diseases of Humans: Dynamics and Control. 2nd Edn. Oxford: Oxford University Press, 1991."},{"key":"key\n\t\t\t\t20170712061014_R26","unstructured":"CDSC. A second dose of MMR vaccine for children in the United Kingdom. Commun Dis Rep1996;6:259."},{"key":"key\n\t\t\t\t20170712061014_R27","doi-asserted-by":"crossref","unstructured":"Miller E, Rush M, Morgan-Capner P, Hutchinson D, Hindle L. Immunity to diphtheria in adults in England. Br Med J1994;308:598.","DOI":"10.1136\/bmj.308.6928.598b"},{"key":"key\n\t\t\t\t20170712061014_R28","unstructured":"Chief Medical Officer. Immunisation update. CMO's Update1994;2:1\u20132."},{"key":"key\n\t\t\t\t20170712061014_R29","doi-asserted-by":"crossref","unstructured":"Fairley CK, Miller E. Varicella-zoster virus epidemiology\u2014a changing scene. J Infect Dis1996;174:S314\u201319.","DOI":"10.1093\/infdis\/174.Supplement_3.S314"},{"key":"key\n\t\t\t\t20170712061014_R30","doi-asserted-by":"crossref","unstructured":"Gay NJ, Morgan-Capner P, Wright J, Farrington CP, Miller E. Age-specific antibody prevalence to hepatitis A: implications for disease control. Epidemiol Infect1994;113:113\u201320.","DOI":"10.1017\/S0950268800051529"},{"key":"key\n\t\t\t\t20170712061014_R31","doi-asserted-by":"crossref","unstructured":"Ramsay M, Gay N, Balogun MA, Collins M. Control of hepatitis B in the UK. Vaccine1998;16:S52\u201355.","DOI":"10.1016\/S0264-410X(98)00295-3"},{"key":"key\n\t\t\t\t20170712061014_R32","doi-asserted-by":"crossref","unstructured":"Miller E, Fairley CK, Cohen BJ, Seng C. Immediate and long term outcome of human parvovirus B19 infection in pregnancy. Br J Obstet Gynaecol1998;105:174\u201378.","DOI":"10.1111\/j.1471-0528.1998.tb10048.x"},{"key":"key\n\t\t\t\t20170712061014_R33","doi-asserted-by":"crossref","unstructured":"Gray JJ, Jiang P, Morgan-Capner P, Desselburger U, Estes K. Prevalence of antibodies to Norwalk virus in England: detection by ELISA using baculovirus-expressed Norwalk virus capsid antigen. J Clin Microbiol1993;31:1022\u201325.","DOI":"10.1128\/JCM.31.4.1022-1025.1993"}],"container-title":["International Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ije\/article-pdf\/29\/2\/362\/18478185\/290362.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T08:22:56Z","timestamp":1583310176000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ije\/article-lookup\/doi\/10.1093\/ije\/29.2.362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,4]]},"references-count":33,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2000,4]]},"published-print":{"date-parts":[[2000,4]]}},"URL":"https:\/\/doi.org\/10.1093\/ije\/29.2.362","relation":{},"ISSN":["1464-3685","0300-5771"],"issn-type":[{"value":"1464-3685","type":"electronic"},{"value":"0300-5771","type":"print"}],"subject":[],"published":{"date-parts":[[2000,4]]}}}